ArticleBMC cancer2021

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.

Luis D Borrero-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.